LETICIA GONZALEZ-MAYA

Dr. LETICIA GONZALEZ-MAYA

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2005 in Gynecologic Oncology
Verified
Journal Article
Closed access
MRMaría Alexandra Rodríguez-Sastre
María Alexandra Rodríguez-Sastre
LGLETICIA GONZALEZ-MAYA
LETICIA GONZALEZ-MAYA
RDRicardo Delgado
Ricardo Delgado
MLMarcela Lizano
Marcela Lizano
GTGerardo Tsubaki
Gerardo Tsubaki
AGAlejandro García-Carrancá
Alejandro García-Carrancá

1 August 1998 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
CZCheng-Cai Zhang
Cheng-Cai Zhang
LGLETICIA GONZALEZ-MAYA
LETICIA GONZALEZ-MAYA
VPVincent Phalip
Vincent Phalip
Bacteria usually use two-component systems for signal transduction, while eukaryotic organisms employ Ser/Thr and Tyr kinases and phosphatases for the same purpose. Many prokaryotes turn out to harbor Ser/Thr and Tyr kinases, Ser/Thr and Tyr phosphatases, and their accessory components as well. The sequence determination of the genome of the cyanobacterium Synechocystis sp. strain PCC 6803 offers the possibility to survey the extent of such molecules in a prokaryotic organism. This cyanobacterium possesses seven Ser/Thr kinases, seven Ser/Thr and Tyr phosphatases, one protein kinase interacting protein, one protein kinase regulatory subunit and several WD40-repeat-containing proteins. The majority of the protein phosphatases presented in this study were previously reported as hypothetical proteins. We analyze here the structure and genetic organization of these ORFs in the hope of providing a guidance for their functional analysis. Unlike their eukaryotic counterparts, many of these genes are clustered on the chromosome, and this genetic organization offers the opportunity to study their possible interaction. In several cases, genes of two-component transducers are found within the same cluster as those encoding a Ser/Thr kinase or a Ser/Thr phosphatase; the implication for signal transduction mechanism will be discussed.

11 January 2019 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
ACAldo F. Clemente‑Soto
Aldo F. Clemente‑Soto
ESEnrique Salas‑Vidal
Enrique Salas‑Vidal
CMCésar Millán-Pacheco
César Millán-Pacheco
OPOscar Peralta‑Zaragoza
Oscar Peralta‑Zaragoza
JSJessica Nayelli Sánchez‑Carranza
Jessica Nayelli Sánchez‑Carranza
LGLETICIA GONZALEZ-MAYA
LETICIA GONZALEZ-MAYA
Cervical cancer is the second most common cancer in women worldwide. Human papillomavirus (HPV) infection appears to be a necessary factor in the development of almost all cases (>95%) of cervical cancer. HPV E6 induces a change of control of p53 stabilization from Hdm2 to E6/E6AP in HPV‑infected cells. It is well known that the LxxLL motif of cellular ubiquitin ligase E6AP binds to the pocket of E6 and causes a conformational change to enable E6 to bind p53 competently. In the ternary complex E6/E6AP/p53, p53 is polyubiquitinated by E6AP and subsequently degraded by a proteasome. Therefore, these cells are deficient in the processes regulated by p53, including apoptosis, damaged DNA repair, and the cell cycle. In the present study, it was demonstrated that quercetin induced G2 phase cell cycle arrest and apoptosis in both HeLa and SiHa cells, accompanied by an increase of p53 and its nuclear signal. It was also observed that quercetin increased the level of the p21 transcript and the pro‑apoptotic Bax protein, which are two p53‑downstream effectors. However, quercetin did not alter the expression of the HPV E6 protein in cervical cancer cells; therefore, the increase in p53 occurred in an E6 expression‑independent manner. Furthermore, molecular docking demonstrated that quercetin binds stably in the central pocket of E6, the binding site of E6AP. These data suggest that quercetin increases the nuclear localization of p53 by interrupting E6/E6AP complex formation in cervical cancer cells.

27 July 2022 in Molecules
Verified
Journal Article
Open access
PDF file
BBBenjamín Robles Bañuelos
Benjamín Robles Bañuelos
Lorena María Durán-RiverollLorena María Durán-Riveroll
Lorena María Durán-Riveroll
EREdgar Rangel
Edgar Rangel
Hugo Isidro PérezHugo Isidro Pérez
Hugo Isidro Pérez
LGLETICIA GONZALEZ-MAYA
LETICIA GONZALEZ-MAYA
The marine environment is highly diverse, each living creature fighting to establish and proliferate. Among marine organisms, cyanobacteria are astounding secondary metabolite producers representing a wonderful source of biologically active molecules aimed to communicate, defend from predators, or compete. Studies on these molecules’ origins and activities have been systematic, although much is still to be discovered. Their broad chemical diversity results from integrating peptide and polyketide synthetases and synthases, along with cascades of biosynthetic transformations resulting in new chemical structures. Cyanobacteria are glycolipid, macrolide, peptide, and polyketide producers, and to date, hundreds of these molecules have been isolated and tested. Many of these compounds have demonstrated important bioactivities such as cytotoxicity, antineoplastic, and antiproliferative activity with potential pharmacological uses. Some are currently under clinical investigation. Additionally, conventional chemotherapeutic treatments include drugs with a well-known range of side effects, making anticancer drug research from new sources, such as marine cyanobacteria, necessary. This review is focused on the anticancer bioactivities of metabolites produced by marine cyanobacteria, emphasizing the identification of each variant of the metabolite family, their chemical structures, and the mechanisms of action underlying their biological and pharmacological activities.

22 April 2017 in Molecules
Verified
Journal Article
Open access
PDF file
JCJessica N. Sanchez Carranza
Jessica N. Sanchez Carranza
LÁLaura Álvarez
Laura Álvarez
SMSilvia Marquina
Silvia Marquina
ESEnrique Salas-Vidal
Enrique Salas-Vidal
VCVerónica Cuevas
Verónica Cuevas
LGLETICIA GONZALEZ-MAYA
LETICIA GONZALEZ-MAYA
Caesalpinia coriaria (C. coriaria), also named cascalote, has been known traditionally in México for having cicatrizing and inflammatory properties. Phytochemical reports on Caesalpinia species have identified a high content of phenolic compounds and shown antineoplastic effects against cancer cells. The aim of this study was to isolate and identify the active compounds of a water:acetone:ethanol (WAE) extract of C. coriaria pods and characterize their cytotoxic effect and cell death induction in different cancer cell lines. The compounds isolated and identified by chromatography and spectroscopic analysis were stigmasterol, ethyl gallate and gallic acid. Cytotoxic assays on cancer cells showed different ranges of activities. A differential effect on cell cycle progression was observed by flow cytometry. In particular, ethyl gallate and tannic acid induced G2/M phase cell cycle arrest and showed interesting effect on microtubule stabilization in Hep3B cells observed by immunofluorescence. The induction of apoptosis was characterized by morphological characteristic changes, and was supported by increases in the ratio of Bax/Bcl-2 expression and activation of caspase 3/7. This work constitutes the first phytochemical and cytotoxic study of C. coriaria and showed the action of its phenolic constituents on cell cycle, cell death and microtubules organization.

1 January 2019 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Open access
SMSilvia Marquina
Silvia Marquina
MMMaritza Maldonado-Santiago
Maritza Maldonado-Santiago
JSJessica Nayelli Sánchez-Carranza
Jessica Nayelli Sánchez-Carranza
Mayra Antunez-MojicaMayra Antunez-Mojica
Mayra Antunez-Mojica
LGLETICIA GONZALEZ-MAYA
LETICIA GONZALEZ-MAYA
LÁLaura Álvarez
Laura Álvarez
Eleven 4'-alkoxy chalcones were synthesized and biologically evaluated for their antiproliferative activity against four human tumor cell lines (PC-3, MCF-7, HF-6, and CaSki). Compounds 3a-3d and 3f were selective against PC-3, with IC50 values ranging from 8.08 to 13.75 μM. In addition, chalcones 3a-3c did not affect the normal fibroblasts BJ cells. The most active and selective compounds were further evaluated for their effect on the progression of cell cycle in PC-3 cells, and chalcones 3a and 3c induced a G2/M phase arrest. Furthermore, it was found that these three chalcones induced the mitochondrial apoptotic pathway by regulating Bax and Bcl-2 transcripts and by increasing caspase 3/7 activation. Otherwise, the QSAR model indicates that the double bond of the α,β-unsaturated carbonyl, as well as the planar structure geometry, are important to the biological activity of the synthetized chalcones. Based on these studies, it was concluded that withdrawing substituents in ring A, decrease the antiproliferative activity. This is related to the possible mechanism of action of these compounds, where a Michael addition needs to take place in order to be a potent anticancer agent.